We strive to treat everyone the way we would want to be treated
Recalls & Warnings February 11, 2020 FTC Sues Two Companies Selling Bone Health and Joint Pain Supplements On February 11, 2020, the Federal Trade Commission (FTC) announced that it sued two companies to stop them from continuing to make false claims about their bone and joint health products, Ostinol (ZyCal Bioceuticals) and StimTein (Excellent Marketing Results, Inc
Acute injuries may respond in 4 weeks, while chronic conditions often benefit from 6-8 week cycles
In both mouse and human cells, the researchers showed that the plant-derived drug caused a variety of cell types, including oral-tissue cells and osteoblasts, or bone-building cells, to grow and differentiate, or divide to form a variety of different cell types
5mg BPC-157 + 5mg TB-500 per vial - standard recovery-research ratio
Angiogenesis & VEGFR2 Mechanism Hsieh et al., Journal of Molecular Medicine (2017) Hsieh and colleagues investigated the pro-angiogenic effects of BPC-157 across multiple experimental systems: a chick chorioallantoic membrane (CAM) assay, an endothelial tube-formation assay, and a rat hindlimb ischemia model assessed by laser Doppler scanning